Motley Fool Australia

Could these small cap ASX shares be the next Afterpay (ASX:APT) or Zip (ASX:Z1P)?

Woman in mustard yellow blouse on laptop holds both hands out to either side with graphic illustration of question marks above them
Image source: Getty Images

It wasn’t that long ago that Afterpay Ltd (ASX: APT) and Zip Co Ltd (ASX: Z1P) were small cap shares and largely unknown to the average investor.

Today they are multi-billion dollar companies and among the most popular shares on the S&P/ASX 200 Index (ASX: XJO).

Anyone that picked up shares when they were still small caps will have generated mouth-watering returns.

I think this demonstrates why a little exposure to the small side of the market can be a good thing for a portfolio.

But which small cap shares should you be looking at? Three small caps that I think have a lot of potential are listed below:

Bigtincan Holdings Ltd (ASX: BTH)

The first small cap to watch is Bigtincan. It is a provider of enterprise mobility software. This increasingly popular software allows sales and service organisations to increase sales win rates, reduce expenditures, and improve customer satisfaction through improved mobile worker productivity. It has a large number of blue chips using its software. This includes banking giant Australia and New Zealand Banking GrpLtd (ASX: ANZ), Nike, and Sephora.

Clover Corporation Limited (ASX: CLV)

Clover is a specialist ingredients producer that manufactures ingredients such as the highly sought-after omega-3 oils that go into infant formula, supplements, and baby food products. It has been growing at a strong rate over the last few years thanks largely to the increasing demand for ingredients from infant formula market. While uncertain trading conditions could bring this positive run to an end in FY 2021, I believe this is only a short term headwind and its growth will accelerate again once the conditions ease.

Volpara Health Technologies Ltd (ASX: VHT)

A final small cap to watch is Volpara. It is a Software-As-A-Service (SaaS) company that uses algorithms and artificial intelligence to improve the early detection of breast cancer. It achieves this by analysing mammograms and associated patient data. After which, the software is able to provide clinical decision support and practice management tools in a cost-effective way. The company is currently generating NZ$19.1 million in annual recurring revenues (ARR) but estimates that it has a US$750 million ARR opportunity in breast cancer screening. 

These 3 stocks could be the next big movers in 2020

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

*Returns as of 6/8/2020

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends BIGTINCAN FPO. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Clover Limited, VOLPARA FPO NZ, and ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended BIGTINCAN FPO and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Related Articles...